SHPHF (Sihuan Pharmaceutical Holdings Group) EPS (Basic): $0.00 (TTM As of Dec. 2025)

What is Sihuan Pharmaceutical Holdings Group EPS (Basic)?

Sihuan Pharmaceutical Holdings Group SHPHF 52 EPS (Basic) is $0.00 as of Dec. 2025. GuruFocus rates SHPHF with a GF Score™ of 52/100 and a GF Value™ of $0.17 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Sihuan Pharmaceutical Holdings Group's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.

Sihuan Pharmaceutical Holdings Group's EPS (Diluted) for the six months ended in Dec. 2025 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.

Sihuan Pharmaceutical Holdings Group's EPS without NRI for the six months ended in Dec. 2025 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sihuan Pharmaceutical Holdings Group's highest 3-Year average EPS without NRI Growth Rate was 63.00% per year. The lowest was -35.50% per year. And the median was 27.30% per year.

Sihuan Pharmaceutical Holdings Group (OTCPK:SHPHF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sihuan Pharmaceutical Holdings Group EPS (Basic) Related Terms

Sihuan Pharmaceutical Holdings Group EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Sihuan Pharmaceutical Holdings Group's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sihuan Pharmaceutical Holdings Group EPS (Basic) Chart

Sihuan Pharmaceutical Holdings Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

0.01

-0.03

-0.00

0.00

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
EPS (Basic)	Get a 7-Day Free Trial															0.00	0.00	-0.00	0.00	0.00

52GF Score

Sihuan Pharmaceutical Holdings Group Ltd SHPHF

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sihuan Pharmaceutical Holdings Group EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sihuan Pharmaceutical Holdings Group's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(25.513	-	0)	/	9120.544
	=	0.00

Sihuan Pharmaceutical Holdings Group's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(10.946	-	0)	/	9037.076
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of $0.00 mean?

Sihuan Pharmaceutical Holdings Group (SHPHF) has a EPS (Basic) of $0.00 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors.

Is Sihuan Pharmaceutical Holdings Group's EPS (Basic) too high?

Sihuan Pharmaceutical Holdings Group's current EPS (Basic) is $0.00. Overall, Sihuan Pharmaceutical Holdings Group has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Sihuan Pharmaceutical Holdings Group's EPS (Basic) compare to ZTS?

Sihuan Pharmaceutical Holdings Group's EPS (Basic) of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Drug Manufacturers company?

A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. Sihuan Pharmaceutical Holdings Group's current EPS (Basic) is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?

Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.17, compared to a current price of $0.13 — trading 23.7% below its estimated fair value. The current EPS (Basic) is $0.00. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current EPS (Basic) is $0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued. The current stock price of $0.13 is trading 23.7% below its estimated GF Value™ of $0.17. GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.

Key valuation signals for SHPHF:

EPS (Basic): $0.00
GF Value™: $0.17 vs. price of $0.13 (23.7% below fair value)
GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sihuan Pharmaceutical Holdings Group Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies HKSE:02186 HKSE:02575 HKSE:02652 HKSE:00570 HKSE:02005 HKSE:01349 HKSE:02877 HKSE:06185 HKSE:03613 HKSE:02627 XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Other Exchanges 00460:Hong Kong TEL1:Germany

Address 1 Harbour Road, Convention Plaza, Room 4905, Office Tower, Wanchai, HKG

Website https://www.sihuanpharm.com

Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.

52GF Score

Get the complete analysis for SHPHF

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13

Price

$0.17

GF Value

View SHPHF Analysis

See EPS (Basic) data for all stocks →